Tell us about you

Work Email required

Organization required

First Name required

Last Name required

Job Title required

Phone required (###) ###-####, or int ######...

City required

State/Province required

Tell us about your organization

error messages will go here...

Looks like we’re already familiar with you!

Please press next to continue with the survey.

Looks like we’re already familiar with you!

According to your account type you are not eligible to take surveys at this time. If this is a mistake, please contact KLAS.

If you are trying to access KLAS research data and reports, an email has been sent to   with a link to login.

If the email doesn't appear in your inbox, ask your IT department to add KLASresearch.com to your company spam filter's "whitelist", and check your email's spam folder.

Membership Commitment

In exchange for giving their feedback, healthcare providers can create an account to get access to industry reports, user commentary, and real-time ratings.

By submitting your account request, you are engaged in patient care as either an employee (or contractor) of your provider organization and that you confirm that you have reviewed and agree to abide by the Terms of Use for this website as updated periodically.

To learn more about how we process and protect your personal data, you may view our Privacy policy.

By submitting your account request, you confirm that you have reviewed and agree to abide by the Terms of Use for this website as updated periodically. To learn more about how we process and protect your personal data, you may view our Privacy policy.

By submitting your account request, you confirm that you have reviewed and agree to abide by the Terms of Use for this website as updated periodically.

To learn more about how we process and protect your personal data, you may view our Privacy policy.

 

To learn more about how we process and protect your personal data, you may view our Privacy policy.

 

To learn more about how we process and protect your personal data, you may view our Privacy policy.

Thank You! Your information was submitted successfully!

Next Steps - An email has been sent to . Please follow its instructions to verify your email, and login.

If the email doesn't appear in your inbox, try asking your IT department to add KLASresearch.com to your company spam filter's "whitelist", and checking your email's spam folder.

Thank You! Your information was submitted successfully!

Next Steps - A KLAS representative will contact you to discuss working with KLAS, typically within 24 to 48 hours.

If you have any further questions please contact info@klasresearch.com or 1-801-226-5120.

Surprise! Looks like we already have an account for you.

An email has been sent to blah@blah.com with a link to login.

If the email doesn't appear in your inbox, try asking your IT department to add KLASresearch.com to your company spam filter's "whitelist", and checking your email's spam folder.

The NBA Playoffs and Dose Monitoring—One Front-Runner, then Everybody Else - Cover

The NBA Playoffs and Dose Monitoring—One Front-Runner, then Everybody Else

The NBA playoffs have been rather exciting and unpredictable this year—filled with lots of interesting story lines. Chicago was knocked out in the first round. Heavily favored Oklahoma City is on the ropes against Memphis. Indiana stands on the brink of a monumental collapse. And then there’s the crazy situation with Donald Sterling and the Los Angeles Clippers. It’s been a wild ride. Even for the casual NBA observer, it’s been must-see TV lately (granted, my wife would argue that Parenthood qualifies as must-see TV, not the NBA). 

In spite of the interesting story lines, one has to wonder whether all the drama of the NBA playoffs will be meaningless after all is said and done. LeBron James and company are poised to hoist the championship trophy yet again with a seemingly easy road through the Eastern Conference and a tired Western Conference foe in the finals. It’s Miami and then everybody else.

Similar to the NBA playoffs and the Miami Heat, the dose monitoring market is highlighted by a clear-cut front-runner. It’s Bayer (Radimetrics) and then everybody else. For our recently published dose monitoring report, KLAS interviewed and measured the mindshare of more than 100 healthcare providers, 83 of whom are seriously looking for a dose monitoring solution. Even though several dose monitoring solutions garnered the attention of provider organizations, Bayer was by far the preferred option.   

GE, reminiscent of the San Antonio Spurs, is a veteran company and has a lot of dose experience. They should not be counted out. But as we’ve seen with the Spurs, do they offer enough firepower to overcome the front-runner? GE was considered nearly as often as Bayer, but Bayer was selected top dog at a clip of almost 3-to-1. Other vendors, like PACSHealth and Imalogix, offer strong up-and-coming solutions but don’t compete for mindshare with the big boys. PACS players Agfa and Sectra also now offer homegrown dose monitoring solutions of their own, and these show promise. Up and coming but not considered a serious contender yet? Sound familiar? Hmmm, young and fun-to-watch team but not a serious contender yet? Oklahoma City? Golden State Warriors, anyone? 

Radiology Dose Monitoring 2014: Provider Strategies in an Evolving Market

Klas blogs

Latest tweets